ON-DEMAND WEBINARS

Tune in as Castor’s Director of Solutions Consulting Kristen Harnack illustrates how a modular approach to clinical technology can help you conduct an RWE study.

Watch as experts from ActiGraph, Bellerophon Therapeutics, and IQVIA come together to explore the obstacles and potential breakthroughs in rare disease research.

In this webinar, panelists discuss how connecting sources of real world data (RWD) to clinical trial enables many benefits, including the ability to supplement data for patients lost to follow up and augment trial data to help explain non-responders and adverse events.

Learn how to synthesize individual symptomatic data into a comprehensive narrative of tolerability, ultimately enhancing the clinical value and regulatory positioning of your oncology assets.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

John Oncea Editor